Early outcome of a 31‐gene expression profile test in 86 AJCC stage IB‐II melanoma patients. A prospective multicentre cohort study

BACKGROUND: The clinical and pathological features of primary melanoma are not sufficiently sensitive to accurately predict which patients are at a greater risk of relapse. Recently, a 31‐gene expression profile (DecisionDx‐Melanoma) test has shown promising results. OBJECTIVES: To evaluate the earl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Eur Acad Dermatol Venereol
Autori principali: Podlipnik, S., Carrera, C., Boada, A., Richarz, N.A., López‐Estebaranz, J.L., Pinedo‐Moraleda, F., Elosua‐González, M., Martín‐González, M.M., Carrillo‐Gijón, R., Redondo, P., Moreno, E., Malvehy, J., Puig, S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Original Articles and Short Reports Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483866/
https://ncbi.nlm.nih.gov/pubmed/30702163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.15454
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
Caricamento...

Documenti analoghi